For citations:
Chapko Ya.S., Dubovichenko D.M., Ruzhnikova A.A., Morozova Yu.A., Motkov A.Yu., Pozdeeva O.I., Bogdanov D.V. Use of empegfilgrastim for primary prevention of febrile neutropenia in patients receiving myelosuppressive therapy. Experience of the Arkhangelsk Clinical Oncological Dispensary. Supportive Therapy in Oncology. 2024;1(2):23-31. (In Russ.) https://doi.org/10.17650/3034-2473-2024-1-2-23-31